Effect of pillbox usage on drug adherence in elderly

Investigating the effect of weekly pill box usage on drug adherence in the elderly with cardiovascular disease referring to Kerman Social Security Clinic, 2017

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160503027736N5

Enrollment

Registered

2018-10-06

Start date

2017-10-05

Completion date

Unknown

Last updated

2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug non-compliance.

Interventions

Intervention 1: In this study, there was an intervention group and a control group. In the intervention group, the weekly pillbox, manufactured by the Spadana Medical Technology Company, was used for

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: Cardiovascular disease such as hypertension, congestive heart failure, myocardial infarction, acute coronary syndrome, atrial fibrillation Age 60 years or older Ability to use pillbox

Exclusion criteria

Exclusion criteria: Being hospitalized

Design outcomes

Primary

Measure	Time frame
Drug adherence. Timepoint: before intervention- One month after intervention. Method of measurement: Morisky 8 drug adherence questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahin Heidari

Rafsanjan University of Medical Sciences

sh.heidari@rums.ac.ir+98 34 3425 5900

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026